The Full Wiki

Rizatriptan: Wikis

Advertisements
  
  

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

Rizatriptan
Systematic (IUPAC) name
N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1 H-indol-3-yl]ethanamine
Identifiers
CAS number 145202-66-0
ATC code N02CC04
PubChem 5078
DrugBank APRD00008
Chemical data
Formula C 15H19N5  
Mol. mass 269.345 g/mol
Pharmacokinetic data
Bioavailability 45%
Protein binding 14%
Metabolism by monoamine oxidase
Half life 2–3 hours
Excretion 82% urine; 12% faeces
Therapeutic considerations
Pregnancy cat. C
Legal status
Routes Oral
 Yes check.svgY(what is this?)  (verify)

Rizatriptan (Maxalt) is a 5-HT1 agonist triptan drug developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT).

Maxalt obtained approval by the United States Food and Drug Administration (FDA) on June 29, 1998. It is a second-generation triptan.

Rizatriptan is available only by prescription in the United States, Canada and New Zealand. Similarly, it is classed as a POM (Prescription Only Medicine) in the United Kingdom, Italy (as Rizaliv) and Israel (as Rizalt).

Contents

Use

Rizatriptan is used to treat acute migraine attacks. It does not prevent future migraine attacks.

Advertisements

Indications

Contraindications

Adverse effects

Severe:

Atypical sensations:

Cardiovascular:

Ear, nose, and throat:

Gastrointestinal:

Muscular:


Neurological:

Respiratory:

Skin:

Miscellaneous:

External links


Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message